Adam Greene is the CTO of Capsci Health, where his work unites a deep background in technology, including research in computational chemistry, trading and reporting systems on Wall Street, and experience in numerous startups, with a personal passion for reinventing healthcare with data and analytics. Prior to founding Capsci, Adam was the founder and CTO of SweetSpot Diabetes Care, Inc, a healthcare company focused on improving the use of data in the treatment of diabetes. SweetSpot was purchased by Dexcom, Inc. (NASDAQ: DXCM) in February 2012, and Adam continued as CTO of the SweetSpot subsidiary through 2014. He worked as a technology Associate at Morgan Stanley and has worked with several technology startups.
Adam received a B.A. in Computer Science from Bowdoin College, with a minor in Biology.